MPLAX | VTPSX | MPLAX / VTPSX | |
Total Expense Ratio | 1.02 | 0.05 | 2,040% |
Annual Report Gross Expense Ratio | 1.02 | 0.05 | 2,040% |
Fund Existence | 15 years | 15 years | - |
Gain YTD | 19.531 | 21.470 | 91% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 513M | 506B | 0% |
Annual Yield % from dividends | 2.19 | 2.86 | 76% |
Returns for 1 year | 17.74 | 17.17 | 103% |
Returns for 3 years | 40.96 | 35.49 | 115% |
Returns for 5 years | 50.78 | 40.38 | 126% |
Returns for 10 years | 80.77 | 58.86 | 137% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBBQ | 23.48 | 0.23 | +0.99% |
Invesco Nasdaq Biotechnology ETF | |||
DFIC | 32.26 | 0.17 | +0.53% |
Dimensional International Core Eq 2 ETF | |||
LDP | 21.18 | 0.06 | +0.28% |
Cohen & Steers Limited | |||
ULVM | 86.78 | N/A | N/A |
VictoryShares US Value Momentum ETF | |||
CPSL | 26.62 | -0.01 | -0.04% |
Calamos Laddered S&P 500 Str Alt Prt ETF |